NSV Partners III LP is 10% Owner at Ventyx Biosciences, Inc. (VTYX). They have made 4 open-market trades across 1 company since 2022, most recently 2023-09-18.
CIK 0001890004
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VTYX | 8,488,787 | $118.8M |
Shares reported on the most recent Form 4, priced at the 2023-09-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTYX | SELL · 10b5-1 | 2023-09-18 | 2023-09-20 | $37.81 | $2.1M | -10.6% | -50.7% | -93.9% |
| VTYX | SELL · 10b5-1 | 2023-07-28 | 2023-08-01 | $37.59 | $429K | -8.7% | -8.4% | -60.7% |
| VTYX | SELL · 10b5-1 | 2023-07-07 | 2023-07-19 | $35.23 | $3.5M | +2.2% | -14.6% | -51.8% |
| VTYX | SELL | 2023-07-03 | 2023-07-06 | $39.00 | $5.2M | -2.4% | -10.8% | -23.1% |
| VTYX | SELL · 10b5-1 | 2023-04-21 | 2023-04-25 | $38.54 | $3.9M | +4.9% | -11.2% | -4.4% |
| VTYX | SELL · 10b5-1 | 2023-04-12 | 2023-04-14 | $30.22 | $3.0M | +17.1% | +15.0% | +13.1% |
| VTYX | SELL | 2022-12-15 | 2022-12-19 | $33.28 | $10.0M | +4.9% | +7.6% | +21.1% |
| VTYX | SELL | 2022-11-30 | 2022-12-02 | $29.01 | $7.9M | +18.4% | +2.9% | +60.3% |
| VTYX | SELL | 2022-11-07 | 2022-11-09 | $29.08 | $114K | +5.2% | +8.6% | +69.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.